AlphaQuest LLC Reduces Holdings in Humana Inc. (NYSE:HUM)

AlphaQuest LLC lessened its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 71.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 629 shares of the insurance provider's stock after selling 1,583 shares during the quarter. AlphaQuest LLC's holdings in Humana were worth $160,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in HUM. Pinnacle Wealth Management Advisory Group LLC grew its holdings in shares of Humana by 3.6% during the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock worth $272,000 after buying an additional 37 shares during the last quarter. Atlas Brown Inc. lifted its position in Humana by 0.6% during the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock worth $1,611,000 after acquiring an additional 38 shares during the period. Moors & Cabot Inc. grew its stake in shares of Humana by 2.5% in the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider's stock valued at $519,000 after purchasing an additional 40 shares during the last quarter. Mather Group LLC. raised its stake in shares of Humana by 21.0% during the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock worth $60,000 after purchasing an additional 41 shares during the last quarter. Finally, Capital Advisors Ltd. LLC lifted its holdings in shares of Humana by 26.1% during the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock worth $53,000 after purchasing an additional 43 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Royal Bank of Canada reissued an "outperform" rating and set a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. StockNews.com downgraded shares of Humana from a "buy" rating to a "hold" rating in a report on Tuesday. JPMorgan Chase & Co. decreased their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a report on Tuesday, February 18th. Piper Sandler increased their target price on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a report on Wednesday, January 15th. Finally, Morgan Stanley decreased their price target on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 12th. Nineteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $285.68.

Humana Trading Down 0.2 %

Shares of HUM traded down $0.50 during mid-day trading on Friday, reaching $266.33. The company had a trading volume of 1,806,260 shares, compared to its average volume of 1,713,226. The stock has a market cap of $32.14 billion, a price-to-earnings ratio of 26.77, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a fifty day simple moving average of $271.39 and a 200-day simple moving average of $278.13. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, sell-side analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend is Friday, March 28th. Humana's payout ratio is currently 35.58%.

Insider Activity

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm's stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.37% of the company's stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.